Dyslipidæmi ved psykisk lidelse

Grimur Høgnason Mohr; Carlo Alberto Barcella; Klara Coello; Lone Baandrup; Filip Krag Knop

Dyslipidæmi ved psykisk lidelse

Grimur Høgnason Mohr, Carlo Alberto Barcella, Klara Coello, Lone Baandrup, Filip Krag Knop

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

9 Downloads (Pure)

Abstract

Dyslipidaemia is a modifiable cause of increased mortality in patients with mental illness. We described prevalence, aetiology and treatment of dyslipidaemia in patients with mental illness. Patients with mental illness have a higher prevalence of dyslipidaemia than the general population due to genetic predisposition, unhealthy lifestyle and/or psychotropic medications. Attention towards early identification of dyslipidaemia, close monitoring, and a low threshold for initiating treatment with lifestyle interventions and lipid-lowering agents are warranted in patients with mental illness.

Bidragets oversatte titel	Dyslipidaemia in patients with mental illness
Originalsprog	Dansk
Artikelnummer	V05210439
Tidsskrift	Ugeskrift for Laeger
Vol/bind	184
Udgave nummer	10
Antal sider	10
ISSN	0041-5782
Status	Udgivet - 2022

Adgang til dokumentet

FulltextForlagets udgivne version, 648 KBLicens: CC BY-NC-ND

https://content.ugeskriftet.dk/sites/default/files/scientific_article_files/2022-03/v05210439_web.pdf

Citationsformater

@article{be0e7a66331b4e2b9ed2f10bdc1a1ebb,

title = "Dyslipid{\ae}mi ved psykisk lidelse",

abstract = "Dyslipidaemia is a modifiable cause of increased mortality in patients with mental illness. We described prevalence, aetiology and treatment of dyslipidaemia in patients with mental illness. Patients with mental illness have a higher prevalence of dyslipidaemia than the general population due to genetic predisposition, unhealthy lifestyle and/or psychotropic medications. Attention towards early identification of dyslipidaemia, close monitoring, and a low threshold for initiating treatment with lifestyle interventions and lipid-lowering agents are warranted in patients with mental illness.",

author = "Mohr, {Grimur H{\o}gnason} and Barcella, {Carlo Alberto} and Klara Coello and Lone Baandrup and Knop, {Filip Krag}",

year = "2022",

language = "Dansk",

volume = "184",

journal = "Ugeskrift for Laeger",

issn = "0041-5782",

publisher = "Almindelige Danske Laegeforening",

number = "10",

}

TY - JOUR

T1 - Dyslipidæmi ved psykisk lidelse

AU - Mohr, Grimur Høgnason

AU - Barcella, Carlo Alberto

AU - Coello, Klara

AU - Baandrup, Lone

AU - Knop, Filip Krag

PY - 2022

Y1 - 2022

N2 - Dyslipidaemia is a modifiable cause of increased mortality in patients with mental illness. We described prevalence, aetiology and treatment of dyslipidaemia in patients with mental illness. Patients with mental illness have a higher prevalence of dyslipidaemia than the general population due to genetic predisposition, unhealthy lifestyle and/or psychotropic medications. Attention towards early identification of dyslipidaemia, close monitoring, and a low threshold for initiating treatment with lifestyle interventions and lipid-lowering agents are warranted in patients with mental illness.

AB - Dyslipidaemia is a modifiable cause of increased mortality in patients with mental illness. We described prevalence, aetiology and treatment of dyslipidaemia in patients with mental illness. Patients with mental illness have a higher prevalence of dyslipidaemia than the general population due to genetic predisposition, unhealthy lifestyle and/or psychotropic medications. Attention towards early identification of dyslipidaemia, close monitoring, and a low threshold for initiating treatment with lifestyle interventions and lipid-lowering agents are warranted in patients with mental illness.

M3 - Tidsskriftartikel

C2 - 35315756

AN - SCOPUS:85126868577

VL - 184

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

SN - 0041-5782

IS - 10

M1 - V05210439

ER -